Pentwater Capital Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Pentwater Capital Management's AGN Position: Q2 2020 in Review
Pentwater Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,694,042 shares — an estimated $300M sold.
Pentwater Capital Management first reported a position in AGN in Q3 2014 and held it in 22 quarters. The position peaked at $1.35B in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Pentwater Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Pentwater Capital Management sold 1,694,042 Allergan plc shares in Q2 2020, an estimated $300M.
- Pentwater Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 22 quarters.
- Pentwater Capital Management's Allergan plc position peaked at $1.35B in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Pentwater Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.